Perspectives on chikungunya vaccinology: from traditional platforms to epitope-driven rational design
Authors:
- 17 June 2026
- journal article
- review article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 701, 127088
Abstract
No abstract availableKeywords
Funding Information
- Hunan University
This publication has 179 references indexed in Scilit:
- Multi-epitope vaccines: charting a new frontier in monkeypox prevention and controlHuman Cell, 2025
- Integrating pan-genome and reverse vaccinology to design multi-epitope vaccine against Herpes simplex virus type-13 Biotech, 2024
- Pan-genome and reverse vaccinology approaches to design multi-epitope vaccine against Epstein-Barr virus associated with colorectal cancerImmunologic Research, 2023
- Chikungunya Virus Vaccine Development: Through Computational Proteome Exploration for Finding of HLA and cTAP Binding Novel Epitopes as Vaccine CandidatesInternational Journal of Peptide Research and Therapeutics, 2022
- In silico T cell epitope identification for SARS-CoV-2: Progress and perspectivesAdvanced Drug Delivery Reviews, 2021
- Effect of a Chikungunya Virus–Like Particle Vaccine on Safety and Tolerability OutcomesJAMA, 2020
- Development of Neutralizing Antibodies against Zika Virus Based on Its Envelope Protein StructureVirologica Sinica, 2019
- Chikungunya Virus-Associated DiseaseCurrent Rheumatology Reports, 2017
- Identification of prohibitin as a Chikungunya virus receptor proteinJournal of Medical Virology, 2012
- An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952–1953Transactions of the Royal Society of Tropical Medicine and Hygiene, 1955